Watchmaker Genomics Boosts Manufacturing Capacity with Major Boulder Campus Expansion
The Flatiron Park facility in Colorado will serve as the Watchmaker Boulder Manufacturing Center of Excellence for reagent manufacturing and will house the company’s manufacturing, quality, R&D, and operations teams. The post Watchmaker Genomics Boosts Manufacturing Capacity with Major Boulder Campus Expansion appeared first on GEN - Genetic Engineering and Biotechnology News .
Watchmaker Genomics has expanded its manufacturing capacity with a major lease at Flatiron Park in Boulder, CO. This facility will more than double the company's production capabilities, allowing for growth in research and development, quality assurance, logistics, and other essential functions. The expansion is expected to create hundreds of new jobs in Colorado, with hiring scheduled in phases as the campus becomes operational by the second half of 2027.
Watchmaker Genomics specializes in creating and manufacturing specialized enzymes, reagents, and kits for analyzing DNA and RNA. Founded in 2019, the company focuses on technologies supporting next-generation sequencing and molecular diagnostics. CEO and co-founder Trey Foskett expressed excitement about the expansion, emphasizing the investment in infrastructure, quality systems, and manufacturing capabilities to serve leading genomics and molecular diagnostics companies at commercial scale.
The Flatiron Park facility, designated as the Watchmaker Boulder Manufacturing Center of Excellence, will house reagent manufacturing, quality, R&D, and operations teams. It will also support the growth of activities governed by Watchmaker's ISO 13485-certified quality management system. This new campus complements the company's existing operations in Cape Town, South Africa, further developing their globally connected research, development, and manufacturing network, serving customers and partners across North America, Europe, and Asia.
According to CFO and operating officer Brian Deneau, this expansion is about more than just additional square footage. It creates the operational foundation for Watchmaker Genomics' next stage of growth, strengthening their ability to combine technical innovation with rigorous quality systems and dependable manufacturing.
Written by urgent.news from GEN Biotechnology's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
